home / stock / btai / btai articles

BTAI Articles, BioXcel Therapeutics Inc. - From 11/14/23

Stock Information
Company Name: BioXcel Therapeutics Inc.
Stock Symbol: BTAI
Market: NASDAQ
Website: bioxceltherapeutics.com
Menu
BTAI BTAI Quote BTAI Short BTAI News BTAI Articles BTAI Message Board
Get BTAI Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. Beyond Air posted a quarterly lo...
Why Is Dementia Focused BioXcel Therapeutics Stock Trading Lower Today? | Benzinga

BioXcel Therapeutics Inc (NASDAQ: BTAI) announced alignment with the FDA's recommendation for a Phase 3 trial in the TRANQUILITY program o...

BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial | Benzinga

BioXcel Therapeutics Inc (NASDAQ: BTAI) announced overall survival (OS) data from its Phase 2 trial of BXCL701 in combination with Merck ...

BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14, 2023 | Benzinga

NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial i...
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results | Benzinga

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% t...

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with...

Nasdaq Down 1.5%; Microsoft Posts Upbeat Results | Benzinga

U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded ...
Investors in BioXcel Therapeutics, Inc. (NASDAQ: BTAI) should contact the Shareholders Foundation in connection with a Lawsuit | Benzinga

SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shar...

Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock | Benzinga

Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and clinical d...

Lifshitz Law PLLC Announces Investigations of ImmunityBio, Inc. (NASDAQ: IBRX), BioXcel Therapeutics, Inc. (NASDAQ: BTAI), Baxter International Inc. (NYSE: BAX) | Benzinga

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQ:IBRX) Lifshitz Law PLLC announces investigation into possible securities...
Previous 10 Next 10